CDK9 and hepatocellular carcinoma: These data indicated that miR‐206 plays its anti‐HCC effect via, at least partially, targeting the CDK9 signaling pathway, suggesting that miR206‐CDK9 pathway may be a novel potential target for the treatment of HCC.